This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Net Cash Flow or Change in Cash and Cash Equivalents of Natus Medical Incorporated with missing and latest data points interpolated. Principal component of the cash flow statement representing the amount of increase (decrease) in cash and cash equivalents. Includes Net Cash Flow from Operations, investing Net Cash Flow from Investing and financing Net Cash Flow from Financing for continuing and discontinued operations, and the effect of exchange rate changes on cash Effect of Exchange Rate Changes on Cash .
|Net Cash Flow or Change in Cash and Cash Equivalents||10 Years Trend|
Compare to Other EquitiesAll Fundamental Data
Natus Medical Net Cash Flow or Change in Cash and Cash Equivalents Over Time